Skip to main content

Table 2 Demographics and SF-36 scores in SSc patients according to the ACR-criteria classification

From: Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses

 

All SSc patients

Limited or diffuse SSc

Undifferentiated SSc

Number of patients

41

31

10

Female

88% (36/41)

90 % (28/31)

80% (8/10)

Mean age (min-max)

58 (23-84)

59.6 (33-84)

54 (23-79)

Mean duration of SSc, years (min-max)

9 (2-40)

10.4 (2-40)

5 (2-13)

Mean duration of Raynaud, years (min-max)

12 (2-40)

12.4 (2-40)

7.5 (2-25)

Lung symptoms

41% (17/41)

48% (15/31)

20% (2/10)

Skin involvement

85% (35/41)

94% (29/31)

60% (6/10)

Raynaud phenomenon

100% (41/41)

100% (31/31)

100% (10/10)

Pitting scars

29% (12/41)

35% (11/31)

10% (1/10)

Digital ulcers

15% (6/41)

19% (6/31)

0%

GI-tract involvement

37% (15/41)

45% (14/31)

10% (1/10)

Arthralgia/arthritis

15% (6/41)

19% (6/31)

0%

PAH

12% (5/41)

13% (4/31)

10% (1/10)

Renal crisis

2% (1/41)

3% (1/31)

0%

Calcinosis cutis

22% (9/41)

29% (9/31)

0%

Karnofski index (min-max)

77% (50-100%)

70% (50-100%)

84% (70-100%)

Rodnan score (min-max)

6.7 (1-31)

8.0 (1-31)

2.8 (1-6)

SF-36 scores mean (min-max)

   

Physical function

65.8 (5.6-100.0)

61.1 (5.6-100.0)

71.0 (33.3-100.0)

Physical role

66.2 (0.0-100.0)

70.2 (0.0-100.0)

54.6 (0.0-100.0)

Bodily pain

59.0 (22.0-100.0)

58.7 (22.0-100.0)

60.1 (25.0-100.0)

General health

53.6 (15.0-97.0)

51.5 (15.0-92.0)

59.4 (18.8-100.0)

Vitality

54.1 (5.0-95.0)

53.3 (5.0-95.0)

56.5 (35.0-75.0)

Social function

76.6 (0.0-100.0)

75.9 (0.0-100.0)

78.8 (50.0-100.0)

Emotional role

73.1 (0.0-100.0)

76.5 (0.0-100.0)

63.0 (0.0-100.0)

Mental health

72.0 (28.0-100.0)

70.7 (28.0-100.0)

75.8 (52.0-88.0)

  1. PAH: pulmonary arterial hypertension.
  2. GI: gastrointestinal.